Estimation of secondary cancer risk after radiotherapy in high-risk prostate cancer patients with pelvic irradiation

被引:10
|
作者
Haciislamoglu, Emel [1 ]
Gungor, Gorkem [2 ]
Aydin, Gokhan [2 ]
Canyilmaz, Emine [1 ]
Guler, Ozan Cem [3 ]
Zengin, Ahmet Yasar [4 ]
Yenice, Kamil Mehmet [5 ]
机构
[1] Karadeniz Tech Univ, Fac Med, Dept Radiat Oncol, Trabzon, Turkey
[2] Acibadem Univ, Dept Radiat Oncol, Istanbul, Turkey
[3] Baskent Univ, Fac Med, Dept Radiat Oncol, Adana, Turkey
[4] Kanuni Res & Educ Hosp, Dept Radiat Oncol, Trabzon, Turkey
[5] Univ Chicago Med, Dept Radiat & Cellular Oncol, Chicago, IL USA
来源
关键词
flattening filter free (FFF); prostate cancer; radiation-induced secondary cancer; radiotherapy (RT); volumetric modulated arc therapy (VMAT); INTENSITY-MODULATED RADIOTHERAPY; ATOMIC-BOMB SURVIVORS; RADIATION-INDUCED CANCER; OF-FIELD PHOTON; CALCULATED RISK; SOLID CANCER; ARC THERAPY; FLATTENING FILTER; 2ND CANCERS; EXPOSURE;
D O I
10.1002/acm2.12972
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We aimed to estimate the risk of secondary cancer after radiotherapy (RT) in high-risk prostate cancer (HRPC) patients with pelvic irradiation. Computed tomography data of five biopsy-proven HRPC patients were selected for this study. Two different planning target volumes (PTV(1)and PTV2) were contoured for each patient. The PTV(1)included the prostate, seminal vesicles, and pelvic lymphatics, while the PTV(2)included only the prostate and seminal vesicles. The prescribed dose was 54 Gy for the PTV(1)with a sequential boost (24 Gy for the PTV2). Intensity-modulated RT (IMRT) and volumetric modulated arc therapy (VMAT) techniques were used to generate treatment plans with 6 and 10 MV photon energies with the flattening filter (FF) or flattening filter-free (FFF) irradiation mode. The excess absolute risks (EARs) were calculated and compared for the bladder, rectum, pelvic bone, and soft tissue based on the linear-exponential, plateau, full mechanistic, and specific mechanistic sarcoma dose-response model. According to the models, all treatment plans resulted in similar risks of secondary bladder or rectal cancer and pelvic bone or soft tissue sarcoma except for the estimated risk of the bladder according to the full mechanistic model using IMRT((6MV;FF))technique compared with VMAT techniques with FFF options. The overall estimation of EAR indicated that the radiation-induced cancer risk due to RT in HRPC was lower for bladder than the rectum. EAR values ranged from 1.47 to 5.82 for bladder and 6.36 to 7.94 for rectum, depending on the dose-response models used. The absolute risks of the secondary pelvic bone and soft tissue sarcoma were small for the plans examined. We theoretically predicted the radiation-induced secondary cancer risk in HRPC patients with pelvic irradiation. Nevertheless, prospective clinical trials, with larger patient cohorts with a long-term follow-up, are needed to validate these model predictions.
引用
收藏
页码:82 / 89
页数:8
相关论文
共 50 条
  • [31] Pelvic lymph node dissection in high-risk prostate cancer
    Haiquel, Luciano
    Cathelineau, Xavier
    Sanchez-Salas, Rafael
    Macek, Petr
    Secin, Fernando
    INTERNATIONAL BRAZ J UROL, 2022, 48 (01): : 54 - 66
  • [32] Postoperative Pelvic Hypofractionated Accelerated Radiotherapy with Cytoprotection (HypoARC) for High-risk or Recurrent Prostate Cancer
    Koukourakis, Michael I.
    Papadopoulou, Aikaterini
    Abatzoglou, Ioannis
    Panteliadou, Marianthi
    Sismanidou, Kyriaki
    Touloupidis, Stavros
    ANTICANCER RESEARCH, 2012, 32 (10) : 4561 - 4568
  • [33] Whole pelvic intensity-modulated radiotherapy for high-risk prostate cancer: a preliminary report
    Joo, Ji Hyeon
    Kim, Yeon Joo
    Kim, Young Seok
    Choi, Eun Kyung
    Kim, Jong Hoon
    Lee, Sang-wook
    Song, Si Yeol
    Yoon, Sang Min
    Kim, Su Ssan
    Park, Jin-hong
    Jeong, Yuri
    Ahn, Hanjong
    Kim, Choung-Soo
    Lee, Jae-Lyun
    Do Ahn, Seung
    RADIATION ONCOLOGY JOURNAL, 2013, 31 (04): : 199 - 205
  • [34] Benefit of Whole Pelvic Radiotherapy Combined with Neoadjuvant Androgen Deprivation for the High-Risk Prostate Cancer
    Milecki, Piotr
    Baczyk, Maciej
    Skowronek, Janusz
    Antczak, Andrzej
    Kwias, Zbigniew
    Martenka, Piotr
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2009,
  • [35] Radiotherapy after prostatectomy in high‑risk prostate cancer
    G. Roviello
    D. Villari
    G. Nesi
    B. Detti
    Clinical and Translational Oncology, 2020, 22 : 2139 - 2140
  • [36] Prostate cancer screening in high-risk patients
    Feingold, RM
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (08) : 1204 - 1204
  • [37] The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer
    Schneider, Uwe
    Lomax, Antony
    Besserer, Juergen
    Pemler, Peter
    Lombriser, Norbert
    Kaser-Hotz, Barbara
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (03): : 892 - 897
  • [38] The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer
    Schneider, U
    Lomax, A
    Besserer, J
    Lombriser, N
    Pemler, P
    Ross, D
    Kaser-Hotz, B
    RADIOTHERAPY AND ONCOLOGY, 2006, 78 : S54 - S54
  • [39] Improved freedom from PSA failure with whole pelvic irradiation for high-risk prostate cancer
    Seaward, SA
    Weinberg, V
    Lewis, P
    Leigh, B
    Phillips, TL
    Roach, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (05): : 1055 - 1062
  • [40] The early result of whole pelvic radiotherapy and stereotactic body radiotherapy boost for high-risk localized prostate cancer
    Lin, Yu -Wei
    Lin, Li -Ching
    Lin, Kuei-Li
    FRONTIERS IN ONCOLOGY, 2014, 4